ZEN Graphene Solutions Ltd (TSX.V: ZEN)
Announced that it has filed a full international patent application for itsZENGuard™ compound under the Patent Cooperation Treaty (PCT). The company elected to file an international patent due to the global opportunities for its technology.
“We believe ourZENGuard™ technology is a key differentiator in the surgical mask market given its antimicrobial properties” […]
|Zen Graphene||TSX.v : ZEN|
|Market cap||C$429 m @ 4.83c|
ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-:ZEN and OTC:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces that it has filed a full international patent application for itsZENGuard™ compound under the Patent Cooperation Treaty (PCT).
The company elected to file an international patent due to the global opportunities for its technology.
Zen Graphene Solutions management comments
“We believe ourZENGuard™ technology is a key differentiator in the surgical mask market given its antimicrobial properties and its ability to significantly reduce the number of viable bacteria and virus particles that pass through the mask material.
“The unique, patent-pending science that enables these attributes is related to the bonding between the graphene oxide and silver, where the silver is chelated on its surface.”
“Importantly, with the submission of our full international patent, Health Canada approval, and commercial opportunities in front of us, we are working diligently to maximize this opportunity for our shareholders.
“Further, this is an important demonstration of our ability to complete the journey from scientific breakthrough, patent filing, regulatory approval, then to commercialization.
“While our immediate focus is on transmission prevention, we look forward to replicating this success with our other healthcare opportunities and beyond.
“Our focus is to develop innovative nanotechnologies with our partners that improve people’s lives, and we believe our current platform has an unparalleled opportunity to accomplish that.”
Greg Fenton, CEO, Zen Graphene Solutions
Guelph University also filed a full international patent application under the PCT for the electrochemical exfoliation process to produce graphene oxide; this technology includes automation.
ZEN has acquired the exclusive global rights to this technology, and it is being transferred from Guelph University to ZEN’s Research and Develop facility for scale up.
About ZEN Graphene Solutions Ltd.
ZEN is a nanotechnology company developing and commercializing next-gen healthcare solutions in the areas of prevention, detection and treatment.
ZEN is currently focused on commercializingZENGuardTM, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.
City Investors Circle is based in the financial district in the City of London
We present interesting and exciting junior mining companies listed on the ASX and TSX stock exchanges to a group of city professionals, and private investors, all of whom are active investors with a mandate to invest in junior mining companies.
Our audience is selected and invited individually to ensure interest and relevance for the presenting company.
Meetings are non deal, small group, highly focused and engaged, with a lively Q and A to follow the main presentation.
We create awareness, and maintain interest in presenting companies by disseminating their future news to our entire investor group via email, social media, and our Monthly Review newsletter.
If you wish to present to our select group of active mining investors, please email firstname.lastname@example.org
This website is not sponsored, we are truly independent, and will always remain so.
Companies featured here have either presented to the Circle in London, or have been selected because they are considered to have interesting projects, in good jurisdictions, run by an experienced management team.
All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be accurate and reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this.
These articles are for awareness and informational purposes only, and are not recommendations in any form. Always consult an investment professional.